Skip to content
lifestyle.gamezon.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nanoscope Therapeutics
Nanoscope Therapeutics to Participate in the 28th Annual H.C. Wainwright Global Investment Conference
September 11, 2026
Nanoscope Therapeutics Announces U.S. Food and Drug Administration Acceptance of Biologics License Application for MOGENRY for the Treatment of Retinitis Pigmentosa with Severe Vision Loss
September 9, 2026
Nanoscope Therapeutics to Present at 2026 American Society of Retina Specialists Annual Scientific Meeting
July 10, 2026
Catalent and Nanoscope Therapeutics Expand Partnership to Support Late-Phase Development and Commercial Supply of Lead Optogenetic Gene therapy, MCO-010
July 7, 2026
Nanoscope Therapeutics to Present Advanced Clinical and Manufacturing Findings at ASGCT 2026 Annual Meeting
May 11, 2026
←
Previous Page
1
2